secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2026-08-14T12:01:16+00:00
Accession:  0001437749-26-027829
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q2 revenue up 13% to $1.9M, net loss narrows 51% to $577K; raises $2.5M
-------------------------------------------------------------------------------

- Q2 revenue $1.92M, up 13% YoY; license fee revenue up 53% to $1.23M.
- Net loss improved to $(577K) or $(0.56)/share vs $(1.17M) or $(2.01)/share in Q2'25; gross margin 87% vs 73%.
- Raised $2.5M via warrant exercise at $4.06/share; cash now over $4.5M; reduced 2025 note by $350K to $325K.
- 1H'26 revenue up 23%, net loss improved 59%; targets profitability in 2H'26.
- New wins: Saudi Arabia education, Portugal national security, Central Bank of Jordan, Alabama credit union; completed 1-for-10 reverse split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926027829/0001437749-26-027829-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926027829/bkyi20260813c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-027829

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer